Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 26, Issue -, Pages 1-9Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2015.09.001
Keywords
-
Categories
Funding
- FEDER through Operational Programme Competitiveness Factors - COMPETE
- FCT - Foundation for Science and Technology [PTDC/BIM-MEC/0651/2012, UID/NEU/04539/2013, SFRH/BD/51677/2011]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/51677/2011, PTDC/BIM-MEC/0651/2012] Funding Source: FCT
Ask authors/readers for more resources
MiRNAs are short, evolutionary conserved noncoding RNA molecules with the ability to control the magnitude of inflammation. The immunosuppressive nature of the brain is sustained by miRNA-dependent regulation of microglial cells, which become activated under neuroinflammatory conditions, such as brain injury and neurodegeneration. The pro inflammatory and suppressive role of the most studied neuroimmune miRNAs, miR-155 and miR-146a, has been recently challenged. Although the molecular targets of these miRNAs remain unchanged across brain diseases, different kinetics of miRNA expression and degradation can produce different immune outcomes and change microglia phenotypes. Here, we discuss current knowledge regarding the implications of disruption of miRNA networks in neuroinflammation and in the pathophysiology of acute and chronic CNS diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available